Our Key Objectives

Based on the lessons learned from the five UK based pharmaceutical success stories of Acambis, Celltech, Galen, Powderject and Shire, to help a small, selected number of emerging pharmaceutical companies, to get ready for a successful IPO (initial public offering) and even more importantly to remain successful thereafter as a public company.

As a key statement, risk management is considered overall the most important factor for a sustainable, winning strategy of a pharmaceutical, R&D based company.

The key business philosophies we believe in are: Therapeutic area focus Geographic focus on key markets Emphasis on out-sourcing, internal focus on core activities only Business enlargement through “Search” (Business Development and M&A) The priority markets are the US (close to 60% $ market share on the world pharmaceutical market) followed by UK, Germany, France, Italy, Spain and Canada.